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Abstract
The European Renal Association-European Dialysis and
Transplant Association (ERA-EDTA) Registry has pro-
duced a new set of primary renal diagnosis (PRD) codes
that are intended for use by afﬁliated registries. It is de-
signed speciﬁcally for use in renal centres and registries
but is aligned with international coding standards sup-
ported by the WHO (International Classiﬁcation of Dis-
eases) and the International Health Terminology
Standards Development Organization (SNOMED Clinical
Terms). It is available as supplementary material to this
paper and free on the internet for non-commercial, clini-
cal, quality improvement and research use, and by agree-
ment with the ERA-EDTA Registry for use by
commercial organizations. Conversion between the old
and the new PRD codes is possible. The new codes are
very ﬂexible and will be actively managed to keep them
up-to-date and to ensure that renal medicine can remain at
the forefront of the electronic revolution in medicine, epi-
demiology research and the use of decision support
systems to improve the care of patients.
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Introduction
Accurate reporting of basic epidemiology data underpins the
practice of medicine, health care planning and social policy.
The European Dialysis and Transplant Association (EDTA)
has promoted epidemiology research since its formation in
1963. The EDTA Registry was established in 1964. At that
time it published a list of diagnoses that led to end-stage
renal failure (ESRF) [1]. This was called the primary renal
diagnosis (PRD) list. In 1983, the EDTA changed its name
to the European Renal Association–European Dialysis and
Transplant Association (ERA-EDTA) and the EDTA Regis-
try became the ERA–EDTA Registry.
Patients who started renal replacement therapy (RRT)
for ESRF in countries afﬁliated to the ERA-EDTA (and
formerly the EDTA) were registered by their renal centres
and were followed up annually. Initially, this was done
by returning a paper form to the Registry ofﬁce where a
computer database was updated. The ERA-EDTA thus
established a voluntary comprehensive, longitudinal,
international registry many years before other medical
specialties and often reported more detailed information
than was available even to national authorities including
incidence, prevalence, diagnosis, treatment modality and
survival.
The adoption of a set of standard diagnostic terms
improves communication and supports data analysis.
Unfortunately, it can also coerce users, impose unrea-
sonable constraints and provide a false sense of accu-
racy. Code sets must be designed and used carefully
with these beneﬁts and limitations in mind. It must be
possible to record events in free text in the primary
medical record in order to preserve details and context
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and to allow previously unrecognized entities to
emerge.
In 2000, the ERA-EDTA Registry ofﬁce, which at that
point was based in London, was reorganized and returned
to Amsterdam [1, 2]. The responsibility for patient regis-
tration and follow-up was devolved on national and
regional renal registries, which collected the data from
renal centres, undertook initial validation and sent them in
an agreed, secure electronic format to the ERA-EDTA
Registry. These data ﬁles were sometimes augmented with
specially collected data and were used to produce annual
reports on incidence, prevalence, treatment methods and
survival and scientiﬁc papers. They demonstrate the con-
tinuing value of good-quality long-term observational
studies [3–6]. However, deﬁciencies imposed by the
limited options for recording the PRDs caused frustration
[7]. This paper describes the development and publication
of a new list of PRD codes that adheres to international
standards and will extend their use and reliability. In line
with the Strengthening the Reporting of Observational
Studies in Epidemiology recommendations for reporting
observational studies [8], we provide background on the
choices made during the development process.
The problem
The ERA-EDTA Registry Committee recognized that
after having served well for nearly 40 years, the old PRD
codes were incomplete and inﬂexible. The terms lacked
deﬁnitions, used the word ‘other’ without qualiﬁcation
and because there were no guidelines, the PRDs were
applied inconsistently between and even within countries.
It was not possible to indicate the accuracy of the code
used and there was no formal mechanism for adding new
codes or retiring redundant ones.
In the 1960s, when the PRDs were introduced, compu-
ters were not widely used in clinical practice, and at that
time, it was important that the list could be printed on a
single sheet of paper.
Initially, there was very limited quality assurance and
data validation, and it was clear that while attempting to
convey the limited but useful insights they had about
patients, some nephrologists were coding with spurious
accuracy (e.g. a PRD of Immunoglobulin A (IgA) nephro-
pathy based purely on clinical presentation). The PRD as-
signed may have reported the clinical diagnosis but it was
sometimes inadequate for secondary uses and epidemiolo-
gical analysis. There was widespread variation in the use
of some codes and it was difﬁcult to ﬁnd the appropriate
codes for some patients, particularly those with systemic
vasculitis, where understanding and classiﬁcation have
changed greatly since the PRD list was ﬁrst agreed. Over
the decades, other new diseases have been described that
did not ﬁt into existing categories. These problems could
not be ﬁxed simply by extending the old PRD list and it
was therefore decided that a completely new list of PRD
terms and a new philosophy for maintaining it would be
produced.
Possible solutions
A Registry Coding and Deﬁnitions Working Group was
established to develop a new list of Primary Renal Diag-
noses and to report to the ERA-EDTA Registry Commit-
tee as part of the QUest European STudies (QUality)
initiative [9]. The brief was: ‘to improve and standardize
the deﬁnitions, terminology and coding used by renal re-
gistries in Europe to describe primary renal diagnoses’.
The ﬁrst task was to review the existing codes and to
seek the views of the national and regional registries af-
ﬁliated to the ERA-EDTA. That was done by a question-
naire and discussion at meetings of registries during
ERA-EDTA congresses. It was apparent that there were
many very different, well-considered and deeply held
views. Some countries had also modiﬁed the code set by
expanding some sections.
A similar problem has been clearly reviewed by Agar
et al. [10] in a paper on the terminology of chronic main-
tenance haemodialysis. They point out that the meaning
of terms varies from one geographical region to another
and that many publications prompt the reader to ask
‘What exactly did they mean?’ They offer suggestions for
improving the situation but realistically warn that changes
will not always be welcomed, particularly by those who
use terms that have been rejected. In the development of
the new PRD codes, we faced the same problem. The key
point is that to be of full use in later epidemiology and
clinical studies, the contextual information or ‘meta data’
which supports the PRD and other clinical data must be
recorded at the same time as the diagnosis and inextric-
ably linked.
In their response to our questionnaire and in subsequent
discussions, renal registries expressed a huge range of
sometimes irreconcilable views concerning the new PRD
terms. It became apparent that many registries and na-
tional authorities were already committed to using the
International Classiﬁcation of Diseases (ICD)-10 or the
SNOMED Clinical Terms (SNOMED CT). The latter no-
menclature offers enormous beneﬁts and is fully main-
tained by the International Health Terminology Standards
Development Organization (IHTSDO), a not-for-proﬁt
multinational association.
The main suggestions from Registries are summarized
in the following list, which retains the telegraphic style of
the questionnaire responses:
(i) simply retain the existing PRD list without modiﬁ-
cation because it has served well and is understood,
(ii) adopt ICD-10 without modiﬁcations,
(iii) adopt SNOMED CTwithout modiﬁcations,
(iv) create a new list to be maintained entirely by the
ERA-EDTA Registry,
(v) create a new list to be maintained by the ERA-
EDTA Registry and keep it aligned with other inter-
national coding schemes,
(vi) include all aspects of a PRD in a single line of text
that does not require further qualiﬁcation,
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(vii) be usable by ordinary clinicians for routine work
with little additional training and produce data for
registry use, decision support and evidence-based
practice as an automatic byproduct from an elec-
tronic medical record,
(viii) acknowledge the uncertainties in clinical practice,
(ix) be acceptable to the ERA-EDTA Registry and af-
ﬁliated registries and if possible compatible with
other international registries,
(x) incorporate or map to the existing ERA-EDTA
PRD codes,
(xi) be consistent with emerging medical standards, e.g.
SNOMED CT and ICD-11,
(xii) be comprehensive and rigorous enough to support
primary and international epidemiology research,
quality improvement, service planning, teaching
and funding,
(xiii) have working deﬁnitions,
(xiv) be ﬂexible so that redundant codes can be retired and
new codes added while maintaining good version
control,
(xv) allow continuing research by combining records
using the old and new PRDs and
(xvi) include more renal disorders and remove the restric-
tion to diseases that result in ESRF and the need
for RRT
It was clear that a ready-made solution was not available.
We adopted plan 5 and attempted to satisfy criteria and
suggestions 6–16.
Materials and methods
The working group corresponded mostly by email and made extensive
use of teleconferencing with a shared virtual PC desktop on which we
could display the work being discussed and which any member could
control and edit. The philosophy was discussed with the registries af-
ﬁliated to the ERA-EDTA, the IHTSDO and the WHO ICD-11 renal
group. An initial set of new PRDs was produced from a list drafted by
one of us (G.V.R.), by reviewing the records produced over a 25-year
period on a comprehensive electronic patient record system in a large
university renal centre (K.S.), by summarizing text books and reviews
(C.R.V.T.) and by suggestions from all members of the working group.
After the working group had produced the initial list of new PRDs, it
was reviewed by registries afﬁliated to the ERA-EDTA, the ERA-EDTA
QUEST initiative, recognized experts and by international renal regis-
tries. We have also followed the advice from coding experts that we
should avoid terms that included the concept of ‘other’. This is of sufﬁ-
cient importance that a short note is appropriate here. The old PRDs
made extensive use of the term ‘other’ to describe things that did not ﬁt
anywhere else. This is the common strategy adopted by classiﬁcation
systems that are attempting to achieve complete coverage. The concept of
‘other’ is used in two distinct ways: for residual categories where the code
could be more accurate but the correct term cannot be found, e.g. ‘Not
Elsewhere Classiﬁed (NEC)’, ‘due to other cause’ and ‘other speciﬁed
type’, and secondly for cases where more detailed information is not avail-
able, e.g. ‘Not Otherwise Speciﬁed (NOS)’ and ‘cause not speciﬁed’.
These are often referred to as the ‘NOS and NEC codes’. They are
designed to be used in classiﬁcation systems rather than as part of a true
coded terminology system for clinical diagnosis. Although they are in-
tended to allow the best possible choice from a limited data set, they
have unfortunately been used inconsistently. While ‘NOS and NEC’
codes allow quick data entry, they often render data less useful for
analysis.
Even with good version control, it is often not clear what alternatives
were available when a ‘NOS’ code was used, and therefore, it was
unclear what it might include or exclude. Furthermore, ambiguity is in-
troduced when new codes are added because the domain deferred to
‘other’ changes every time the code set is altered.
Modern medical terminology systems try to avoid this problem by
capturing clinical information at the level of detail appropriate for clini-
cal practice and by allowing new codes to be added in an easy but con-
trolled way. The approach now favoured is to provide high-level (also
called ‘generic’, ‘less granular’ or ‘super concept’) terms like ‘glomeru-
lonephritis’, ‘familial nephropathy’ and ‘chronic renal failure (CRF)’ and
to use these super concepts in four distinct settings:
(i) where a sound diagnosis of a well-described condition has been
made but an appropriate code cannot be found in the code set being
used,
(ii) where the user thinks that a new disorder or syndrome has been re-
cognized,
(iii) where a patient is still being investigated and the ﬁnal diagnosis has
not yet been determined but where a general diagnosis can be made
and
(iv) where a user, for a particular purpose, does not need or want to
work with a very accurate code.
It is possible, for example, to enter and store Goodpasture’s syndrome
and to report it simply as a glomerulopathy or even just as a renal
disease if only a summary report is required. The internal relationships
that underpin SNOMED-CT link Goodpasture’s to lung diseases, vascu-
litis and autoimmune diseases. This allows complex analysis of huge da-
tabases and enables appropriate literature to be linked to individual
patient records for optimal clinical practice and decision support. Care
must be taken when generating detailed (granular) terms from a diagno-
sis that was initially saved at a generic (less granular) level but the utility
of automatically providing all the available attributes of a diagnostic
term is obvious.
The new PRD list
The 2012 ERA-EDTA PRD codes are published as Sup-
plementary material to this paper. In addition, they are
freely available in a spreadsheet and in a searchable web
browser on the ERA-EDTA Registry website at www.era-
edta-reg.org.
As requested by the national registries, the 273 new
PRD terms not only include all the common and many
rare nephropathies that result in ESRF, but also many
other kidney conditions which do not usually cause ad-
vanced chronic kidney disease (CKD).
In the list, each new PRD term has been assigned a
unique number, which serves only to identify it and to
help electronic communication. We came to the con-
clusion that a single hierarchy of codes would be imposs-
ible. For example, it would be equally logical to include
familial IgA nephropathy in a ‘familial’ category or in a
‘glomerulonephritis’ category. The many complex ways
in which lists of diagnoses can be searched, sorted and
examined are already well handled in SNOMED CT
and these tools will be available when the new PRD
terms are accessed on a modern computer browser. A
default sorting order decided by the working group is in-
cluded so that if required, the list can be viewed in a stan-
dard order. This default order has no particular
signiﬁcance and users can rearrange the list and use any
convenient software tools to search, sort and manipulate
it. If required, printed copies can be used. Suggestions for
addition or inactivation of terms should be sent to the
ERA–EDTA Registry ofﬁce at erareg@amc.uva.nl.
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Further details about the codes and their attributes are
given in ‘Notes for Users’ which are published with the
codes. An unusual feature of the PRDs is the inclusion of
the term ‘histologically proven’ and ‘no histology’ even
for some PRDs, which should not reasonably be used
without histological evidence. These terms are used to
satisfy the requirement to provide detail, as a measure of
the certainty of the diagnosis and to say everything in a
single line of text. We provide PRDs that contain the
words ‘no histology’ for diagnoses that clearly require
histological proof (eg ‘IgA nephropathy - no histology’). It
is clear from Registry records that PRDs which describe
the histological appearance of a kidney biopsy are fre-
quently used even when histological evidence is not avail-
able and an alternative less granular PRD would be more
suitable. We do not condone this practice. We hope that
nephrologists who wish to record such a diagnosis will use
the PRD which contains the words ‘no histology’ so that if
required they can be analysed separately from the similar
PRD which contains the words ‘histologically proven’. We
hope that it will henceforth be possible to distinguish an
honest guess from a ﬁrm diagnosis using gold standard cri-
teria, and we recognize that as new and accurate non-histo-
logical diagnostic techniques (e.g. genetic tests) are
developed, additional codes will be needed to include and
speciﬁcally exclude these options. For Registry purposes,
only one PRD code can be assigned to a patient.
Two examples of common clinical situations with the
old PRD terms which might have been used and the new
PRDs which are now available will illustrate the utility of
the new list.
Example 1
An adult patient presents with a vasculitic rash and a
rising serum creatinine. Haematuria and proteinuria are
present. Tests for Anti-Neutrophil Cytoplasmic Antibody
(ANCA) are strongly positive. Kidney biopsy is techni-
cally impossible because of obesity. A clinical diagnosis
of microscopic polyangiitis is made, and the patient re-
sponds well to immunosuppressive treatment.
With the old classiﬁcation, the patient might have been
allocated one of the following codes:
00 Chronic renal failure; aetiology uncertain,
10 Glomerulonephritis; histologically NOT examined,
74 Wegener’s granulomatosis,
89 Multi-system disease—other and
99 Other identiﬁed renal disorders.
With the new codes, we will probably use either:
1396 Systemic vasculitis—ANCA positive—no his-
tology or
1401 Granulomatosis with polyangiitis – no histology
Example 2
A 60-year-old patient with morbid obesity is referred with an
estimated glomerular ﬁltration rate of 28 mL/min/1.73 m2.
The patient has had diabetes mellitus (DM) for 10 years
and has been treated with insulin for the last 18 months.
There is a past medical history of hypertension, myocardial
infarction, transient ischaemic attacks and intermittent clau-
dication. Dipstick urinalysis is negative. Urine albumin:
creatinine ratio is 7 µg/mmol.
With the old PRD classiﬁcation, the patient might have
been allocated one of the following PRD codes:
00 Chronic renal failure; aetiology uncertain,
72 Renal vascular disease due to hypertension,
80 Diabetes glomerulosclerosis or diabetic nephropathy
—Type I,
81 Diabetes glomerulosclerosis or diabetic nephropathy
—Type II.
We know from previous Registry analyses that many
patients with Type 2 diabetes are incorrectly coded as
Type 1. There is also marked variation in the use of codes
for diabetic glomerulosclerosis, suggesting that clinicians
may have chosen these codes without considering the
possibility of alternative aetiologies for kidney disease in
patients with diabetes mellitus.
The new classiﬁcation gives additional guidance on the
choice of the code in this situation. For instance, the code
‘2337 Diabetic nephropathy in Type II diabetes—no his-
tology’ includes the guidance:
(i) A diagnosis of Type II diabetes mellitus must have
been made.
(ii) For a diagnosis of diabetic nephropathy, proteinuria
must have been documented at some point in the
patient’s history.
(iii) A PRD of diabetic nephropathy is not mandatory in
the presence of DM with proteinuria and alternative
diagnoses can be considered.
(iv) In the absence of renal histology, the differential diag-
nosis will include ‘Chronic kidney disease (CKD) /
chronic renal failure (CRF) - aetiology uncertain/
unknown - no histology’, ischaemic nephropathy, re-
novascular disease and atheroembolic renal disease.
(v) Distinguish from: Inherited/genetic diabetes mellitus
Type II.
In addition, newly described nephropathies have been
added to the PRD coding system, e.g.
2274 Nephropathy related to HIV—no histology,
2288 Nephropathy related to HIV—histologically proven.
Finally, many rare diagnoses were omitted from the old
PRD list but are now included, e.g.
1074 Denys–Drash syndrome,
2929 Dent disease and
2938 Lowe syndrome (oculocerebrorenal syndrome).
When a deﬁnitive test has not been used, there will
always be uncertainty, but the new PRD codes allow both
ERA-EDTA PRD codes 4417
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a clinical diagnosis to be recorded faithfully. At the same
time, by noting the absence of a deﬁnitive test, we can
also convey the degree of uncertainty. Where appropriate,
patient records can be grouped according to the degree of
accuracy and certainty required for a particular analysis
and research teams can decide whether to examine a
small number of patients with accurate diagnoses or larger
numbers with phenotypic similarities. Cohorts can be
combined if required and nothing is lost by using the
more granular coding scheme apart from the slight
additional effort of choosing the best diagnostic term
from a larger list. With computer aids, the extra effort is
trivial although we must recognize that we now have
more diagnostic options than we can commit to memory.
No current coding system in widespread use has full
deﬁnitions. While desirable, this would be a huge task and
would require extensive international and cross-specialty
collaboration. In our PRD list, we have made some pro-
gress by providing partial deﬁnitions that indicate what
type of diagnostic information should be used to support
each PRD but with the exception of histological evidence,
these are not mandatory and we must still rely on the good
judgement of individual nephrologists.
Fortuitously, while the work on the PRDs was proceed-
ing, the renal community in the UK was establishing a
subset of existing renal SNOMED CT codes and they
agreed to incorporate the new ERA–EDTA PRD codes in
their list without modiﬁcation. That work introduced one
of the authors (Y.G.), who is an expert in clinical terminol-
ogy, to the PRD codes. He was co-opted onto the PRD
working group and undertook the detailed mapping of the
new PRDs to SNOMED CT and ICD-10. Not only did that
ensure that the terms favoured by the nephrologists were ac-
ceptable to professional terminologists, but it also allowed
the new PRDs to be aligned to SNOMED CT with all the
subtle semantic links that make it such a powerful tool.
Each new PRD has been linked (often called mapping)
to the most appropriate PRD in the old code set and
vice versa. These translation tables are offered for use
where automated conversion of large numbers of records
is required. For detailed research work where the historic
coding practice is well understood, it may be appropriate
to develop alternative mappings or to re-examine individ-
ual records to ensure that the correct new PRD has been
chosen. They need not be followed slavishly but users are
encouraged to publish the mapping tables they use along
with their results. Conversion from old to new PRDs may
be necessary when historic data are being combined with
contemporary data or when historic data with modern
data analysis techniques that use SNOMED CT or ICD
codes.
In addition to allowing conversion between new and
old PRD codes, a powerful feature of the new PRD
coding system is that the assignment of an ICD-10 code,
a SNOMED CT identiﬁer and where necessary a set of
post-coordinated SNOMED CT codes will allow users
to access the full power and utility of these modern and
internationally supported clinical terminology systems.
The most immediate and obvious beneﬁt of a link to
SNOMED CT may be the provision of validated
translation into other languages and the possibility of par-
ticipating in further translation work if required. This
makes the codes and their extended uses (e.g. links to lit-
erature and semantic links) available to non-English
speakers and allows codes to be entered in one language
and displayed in another. A single example persuaded the
coding group of the utility of this approach. We con-
sidered the diagnosis of ‘renal vein thrombosis’. Using a
SNOMED CT browser and irrespective of the language
that is used or whether the fully speciﬁed name or a local
preferred term is used, the relationship to renal disorders,
venous disorders and thrombotic disorders is clear.
SNOMED CT uses words with which we are familiar but
behind the scenes it preserves the concepts and the true
biological meaning via the codes and not simply by
looking up the words.
The introduction of SNOMED CT into clinical practice
is still at an early stage but its power and potential are
obvious and the ERA-EDTAwill be able to contribute to it
as it develops. The new PRD list also has extensive links
to the Online Mendelian Inheritance in Man (OMIM) data-
base, which is a comprehensive medical and scientiﬁc re-
source maintained by US National Library of Medicine
and the William H. Welch Medical Library at Johns
Hopkins University. The online version was developed by
the US National Center for Biotechnology Information.
The ERA-EDTA Registry will accept patient data
returns using the new PRDs from its contributing regis-
tries from January 2012. It will continue to accept data
using the old PRDs for some time and it will announce
on its website 2 years before the date on which it will no
longer be able to accept the old PRDs.
Further developing the codes and putting
them to use
Future development of the codes will be the responsibility
of the ERA-EDTA Registry committee and its coding
group. The initial task will be to collaborate with other
specialties under the general guidance of IHTSDO to
develop codes relevant to the disorders on the boundary
with another specialty or affecting more than one organ,
e.g. extra-renal vasculitis and amyloidosis. We hope that
national registries and renal centres will help us to improve
the PRD list by notifying the Registry of any errors, omis-
sions, redundancies, clariﬁcations or new terms that are
required. Within the structure of SNOMED CT, there are
stable mechanisms for undertaking this work, which allows
the codes to evolve while retaining all the information in
the existing records.
We believe that we have produced a useful new list of
PRDs which satisﬁes most of the requirements set by renal
registries afﬁliated to the ERA-EDTA and which incorpor-
ates most of the suggestions from colleagues who reviewed
the work.
The new PRD codes will be maintained by the ERA-
EDTA Registry and are aligned with major international
coding schemes.
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Supplementary data
The ‘2012 ERA-EDTA Primary Renal Diagnosis Codes’
are available as supplementary data online at http://ndt.
oxfordjournals.org.
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